The U.S. Food and Drug Administration (FDA) is cautioning consumers against the use of “copycat eye drops,” citing potential contamination leading to eye infections.
The FDA specifically advises against purchasing or using eye drops marketed under the names South Moon, Rebright, or FivFivGo.
These products mimic Bausch + Lomb’s Lumify brand eye drops, which are an FDA-approved over-the-counter product designed for redness relief.
- California RESIDENTS To RECEIVE $500 MONTHLY PAYMENTS In New Guaranteed Income Program: Here Is Who Is Eligible
- Us Job Market Booms With 272,000 New Jobs, But Unemployment Rises Slightly To 4.0%
- Credit Scores Of 720+ See Improved Loan Rates This Week
- Examining The Facts: Fact Check On IRS $8700 Stimulus Check Eligibility & Payment Dates
- Gas Prices On Downward Trend As Fourth Of July Road Trips Approach: AAA
Notably, the mentioned copycat eye drops are deemed unapproved drugs and should not be legally available for sale in the United States.
The FDA highlights that these products claim to treat eye conditions such as glaucoma, a medical condition typically addressed through prescription drugs or surgical interventions.
Additionally, some of these imitated products might display misleading labeling, featuring “Bausch + Lomb” at the top of the packaging, despite potential variations in appearance from the authentic products.
FDA Cautions Against South Moon, Rebright, and FivFivGo
The FDA conducted tests on samples of South Moon and Rebright eye drops purchased online, revealing that South Moon drops were contaminated with Burkholderia cepacia complex, a group of bacteria known for causing antibiotic-resistant infections.
While Rebright testing showed no contamination, the FDA still advises consumers not to use the product.
Testing also indicated that both copycat products lacked brimonidine tartrate, the active ingredient found in Lumify.
FivFivGo samples were not obtained for testing, and the origin of these products remains unclear, prompting an ongoing investigation by the FDA.
No adverse event reports specifically mentioning South Moon, Rebright, or FivFivGo have been received by the FDA.
However, reports related to potentially counterfeit Lumify, including concerns about product quality, eye irritation, pain, and infection, have been noted.
Patients displaying signs or symptoms of an eye infection are advised to consult their healthcare provider or seek immediate medical attention.
The FDA recommends proper disposal of these products.
Additionally, consumers are urged to purchase eye products from reputable retailers, such as state-licensed pharmacies, and exercise caution when dealing with online retailers making false claims about their products.